[Tolerance of the polyvalent adsorbed influenza vaccine Alorbat].

Abstract

A good local and systemic tolerance of the influenza virus vaccine Alorbat was observed after a single administration in 469 patients or after a second administration within 4--6 weeks in 132 patients. An improved manufacturing process led to a higher purity of the vaccine (less protein) and therefore to a diminuation of systemic reactions. In most cases… (More)

Topics

Cite this paper

@article{Peukert1979ToleranceOT, title={[Tolerance of the polyvalent adsorbed influenza vaccine Alorbat].}, author={Manuela Peukert and J{\"u}rgen Pollter}, journal={Fortschritte der Medizin}, year={1979}, volume={97 14}, pages={679-81} }